BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 32231194)

  • 21. M2 macrophages induce ovarian cancer cell proliferation via a heparin binding epidermal growth factor/matrix metalloproteinase 9 intercellular feedback loop.
    Carroll MJ; Kapur A; Felder M; Patankar MS; Kreeger PK
    Oncotarget; 2016 Dec; 7(52):86608-86620. PubMed ID: 27888810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity.
    Goishi K; Higashiyama S; Klagsbrun M; Nakano N; Umata T; Ishikawa M; Mekada E; Taniguchi N
    Mol Biol Cell; 1995 Aug; 6(8):967-80. PubMed ID: 7579712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor.
    Higashiyama S; Iwamoto R; Goishi K; Raab G; Taniguchi N; Klagsbrun M; Mekada E
    J Cell Biol; 1995 Mar; 128(5):929-38. PubMed ID: 7876316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-level expression and purification of soluble bioactive recombinant human heparin-binding epidermal growth factor in Escherichia coli.
    Khalili M; Soleyman MR; Baazm M; Beyer C
    Cell Biol Int; 2015 Jul; 39(7):858-64. PubMed ID: 25712700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased expression of heparin-binding epidermal growth factor-like growth factor as a newly identified pathogenic mechanism of antiphospholipid-mediated defective placentation.
    Di Simone N; Marana R; Castellani R; Di Nicuolo F; D'Alessio MC; Raschi E; Borghi MO; Chen PP; Sanguinetti M; Caruso A; Meroni PL
    Arthritis Rheum; 2010 May; 62(5):1504-12. PubMed ID: 20131286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transactivation of epidermal growth factor receptor after heparin-binding epidermal growth factor-like growth factor shedding in the migration of prostate cancer cells promoted by bombesin.
    Madarame J; Higashiyama S; Kiyota H; Madachi A; Toki F; Shimomura T; Tani N; Oishi Y; Matsuura N
    Prostate; 2003 Nov; 57(3):187-95. PubMed ID: 14518027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validity of HB-EGF as Target for Human Neuroblastoma Therapy.
    Nam SO; Yotsumoto F; Miyata K; Souzaki R; Taguchi T; Kuroki M; Miyamoto S
    Anticancer Res; 2015 Aug; 35(8):4433-40. PubMed ID: 26168483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A targetable HB-EGF-CITED4 axis controls oncogenesis in lung cancer.
    Hsieh CH; Chou YT; Kuo MH; Tsai HP; Chang JL; Wu CW
    Oncogene; 2017 May; 36(21):2946-2956. PubMed ID: 28092674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
    Fan Z; Masui H; Altas I; Mendelsohn J
    Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble form of heparin-binding EGF-like growth factor contributes to retinoic acid-induced epidermal hyperplasia.
    Kimura R; Iwamoto R; Mekada E
    Cell Struct Funct; 2005; 30(2):35-42. PubMed ID: 16357442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The soluble and membrane-anchored forms of heparin-binding epidermal growth factor-like growth factor appear to play opposing roles in the survival and apoptosis of human luteinized granulosa cells.
    Pan B; Sengoku K; Goishi K; Takuma N; Yamashita T; Wada K; Ishikawa M
    Mol Hum Reprod; 2002 Aug; 8(8):734-41. PubMed ID: 12149405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Telmisartan inhibits cell proliferation by blocking nuclear translocation of ProHB-EGF C-terminal fragment in colon cancer cells.
    Ozeki K; Tanida S; Morimoto C; Inoue Y; Mizoshita T; Tsukamoto H; Shimura T; Kataoka H; Kamiya T; Nishiwaki E; Ishiguro H; Higashiyama S; Joh T
    PLoS One; 2013; 8(2):e56770. PubMed ID: 23451083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matrix metalloproteinase-7-catalyzed release of HB-EGF mediates deoxycholyltaurine-induced proliferation of a human colon cancer cell line.
    Cheng K; Xie G; Raufman JP
    Biochem Pharmacol; 2007 Apr; 73(7):1001-12. PubMed ID: 17222808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The metalloproteinase ADAM-12 regulates bronchial epithelial cell proliferation and apoptosis.
    Rocks N; Estrella C; Paulissen G; Quesada-Calvo F; Gilles C; Guéders MM; Crahay C; Foidart JM; Gosset P; Noel A; Cataldo DD
    Cell Prolif; 2008 Dec; 41(6):988-1001. PubMed ID: 19040574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of heparin binding epidermal growth factor-like growth factor in the early phase of regeneration after acute renal injury. Isolation and localization of bioactive molecules.
    Sakai M; Zhang M; Homma T; Garrick B; Abraham JA; McKanna JA; Harris RC
    J Clin Invest; 1997 May; 99(9):2128-38. PubMed ID: 9151785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TGFβ induces proHB-EGF shedding and EGFR transactivation through ADAM activation in gastric cancer cells.
    Ebi M; Kataoka H; Shimura T; Kubota E; Hirata Y; Mizushima T; Mizoshita T; Tanaka M; Mabuchi M; Tsukamoto H; Tanida S; Kamiya T; Higashiyama S; Joh T
    Biochem Biophys Res Commun; 2010 Nov; 402(3):449-54. PubMed ID: 20934403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Localization of CD9, an enhancer protein for proheparin-binding epidermal growth factor-like growth factor, in human atherosclerotic plaques: possible involvement of juxtacrine growth mechanism on smooth muscle cell proliferation.
    Nishida M; Miyagawa J; Yamashita S; Higashiyama S; Nakata A; Ouchi N; Tamura R; Yamamori K; Kihara S; Taniguchi N; Matsuzawa Y
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1236-43. PubMed ID: 10807738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies.
    Baselga J; Norton L; Masui H; Pandiella A; Coplan K; Miller WH; Mendelsohn J
    J Natl Cancer Inst; 1993 Aug; 85(16):1327-33. PubMed ID: 8340945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of proHB-EGF carboxy-terminal fragment nuclear translocation: a new molecular target therapy for gastric cancer.
    Shimura T; Kataoka H; Ogasawara N; Kubota E; Sasaki M; Tanida S; Joh T
    Clin Cancer Res; 2008 Jun; 14(12):3956-65. PubMed ID: 18559618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastrin induces heparin-binding epidermal growth factor-like growth factor in rat gastric epithelial cells transfected with gastrin receptor.
    Miyazaki Y; Shinomura Y; Tsutsui S; Zushi S; Higashimoto Y; Kanayama S; Higashiyama S; Taniguchi N; Matsuzawa Y
    Gastroenterology; 1999 Jan; 116(1):78-89. PubMed ID: 9869605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.